Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Pertuzumab, Trastuzumab, and an Aromatase Inhibitor for HER2-Positive and Hormone Receptor-Positive Metastatic or Locally Advanced Breast Cancer: PERTAIN Final Analysis.
Clin Cancer Res. 2023 Apr 14;29(8):1468-1476. doi: 10.1158/1078-0432.CCR-22-1092.
Clin Cancer Res. 2023.
PMID: 36716289
Free PMC article.
Clinical Trial.
Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication.
Miles D, Ciruelos E, Schneeweiss A, Puglisi F, Peretz-Yablonski T, Campone M, Bondarenko I, Nowecki Z, Errihani H, Paluch-Shimon S, Wardley A, Merot JL, Trask P, du Toit Y, Pena-Murillo C, Revelant V, Klingbiel D, Bachelot T; PERUSE investigators.
Miles D, et al. Among authors: revelant v.
Ann Oncol. 2021 Oct;32(10):1245-1255. doi: 10.1016/j.annonc.2021.06.024. Epub 2021 Jul 2.
Ann Oncol. 2021.
PMID: 34224826
Free article.
Clinical Trial.
Item in Clipboard
Effects of some non-steroidal anti-inflammatory drug copper complexes on polymorphonuclear leukocyte oxidative metabolism.
Roch-Arveiller M, Revelant V, Pham Huy D, Maman L, Fontagne J, Sorenson JR, Giroud JP.
Roch-Arveiller M, et al. Among authors: revelant v.
Agents Actions. 1990 Aug;31(1-2):65-71. doi: 10.1007/BF02003223.
Agents Actions. 1990.
PMID: 2178320
Item in Clipboard
[Trace elements in total parenteral nutrition].
Revelant V.
Revelant V.
Acta Cient Venez. 1990;41(3):171-6.
Acta Cient Venez. 1990.
PMID: 2152376
Review.
Spanish.
Item in Clipboard
Cite
Cite